← FDA Drug Approvals (Drugs@FDA)

DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: COREPHARMA · Approved 2015-11-10

Drug application

FDA Application #

ANDA206721

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

Generic name

Amphetamine Aspartate

Active ingredients

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

COREPHARMA

First approval

2015-11-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown